Stock vs Stock Comparison

ANI Pharmaceuticals, Inc. vs AbbVie Inc.

ANIP wins the Tale of the Tape 5–3.

ANIP
ABBV$217.13

🏆 Tale of the Tape

53
ANIPABBV
8.9%Profitability (Net Margin)6.9%
23.1xValuation (P/E)106.2x
7.9%Efficiency (ROIC)8.3%
7/9Health (Piotroski F)7/9
2.4Safety (Altman Z)2.0
43.8%Growth (Rev YoY)8.6%
Risk (Sharpe 1Y)0.61
1.66xBalance Sheet (D/E)-42.50x
7.42%FCF Yield4.23%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricANIPABBV
Market Cap$1.7B$384.7B
P/E Ratio23.1x106.2x
Forward P/E7.3x13.4x
P/B2.97x-57.80x
Dividend Yield3.18%
Beta0.460.30

Quantitative Metrics

MetricANIPABBV
DCF Fair Value$410.81$126.26
DCF Upside-38.9%
Piotroski F7/97/9
Altman Z2.402.01
Beneish M-2.62-2.87
FCF Yield7.42%4.23%
Net Debt/EBITDA1.5x3.0x
ROIC7.9%8.3%
WACC7.0%7.4%
ROIC – WACC0.9pp0.8pp
Gross Margin61.4%70.2%
Net Margin8.9%6.9%
Rev Growth YoY43.8%8.6%
Sharpe (1Y)0.61
Max Drawdown 3Y
FCF Payout Ratio1%65%

ANIP Price

Loading chart...

ABBV Price

Loading chart...

ETF Exposure

ANIP found in:

XPH1.98%
SLYG0.18%
SPSM0.09%
VHT0.02%
SPTM0.00%

ABBV found in:

XLV7.07%
IYH6.86%
VHT6.04%
HDV5.61%
SCHD3.53%
DGRO2.52%
DGRW1.99%
MGV1.85%
VIG1.68%
VYM1.56%
NOBL1.49%
VTV1.46%
SDY1.42%
IWF1.39%
SCHV1.38%
VONG1.21%
XBI1.09%
ESGV0.78%
SPYV0.71%
IVV0.69%
SPLG0.68%
SCHX0.66%
SCHB0.62%
ITOT0.61%
VOO0.60%
SPY0.59%
VONE0.57%
SPTM0.55%
VTI0.54%
SPYG0.50%
URTH0.48%
ACWI0.41%
VFVA0.41%
VT0.33%
QUS0.32%
VFMV0.25%
RSP0.19%
ONEO0.03%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ANIP vs ABBV: Head-to-Head Analysis

ANI Pharmaceuticals, Inc. (ANIP) and AbbVie Inc. (ABBV) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ANIP leads 5–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ANIP generates a return on invested capital (ROIC) of 7.9% compared to ABBV's 8.3%. This suggests ABBV is more effective at deploying capital to generate shareholder returns.

ANIP appears in 5 ETFs tracked by SecuritiesDB, while ABBV appears in 38 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ANIP or ABBV?

Our quantitative analysis compares ANIP and ABBV across nine fundamental dimensions. ANIP wins the Tale of the Tape 5–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ANIP and ABBV correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.